Robert Blumenthal
Affiliations: | Chemical Biology Laboratory | National Institutes of Health, Bethesda, MD |
Area:
membrane biophysics, viral fusion, liposomes, fluorescence, membrane modeling, HIV entry into cellsWebsite:
https://ccr.cancer.gov/Chemical-Biology-Laboratory/robert-blumenthalGoogle:
"Robert Blumenthal"Bio:
https://www.researchgate.net/profile/Robert_Blumenthal3
Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Klug YA, Ashkenazi A, Viard M, et al. (2014) Early and late HIV-1 membrane fusion events are impaired by sphinganine lipidated peptides that target the fusion site. The Biochemical Journal. 461: 213-22 |
| Gupta K, Jang H, Harlen K, et al. (2013) Mechanism of membrane permeation induced by synthetic β-hairpin peptides. Biophysical Journal. 105: 2093-103 |
| Blumenthal R, Durell S, Viard M. (2012) HIV entry and envelope glycoprotein-mediated fusion. The Journal of Biological Chemistry. 287: 40841-9 |
| Ashkenazi A, Viard M, Unger L, et al. (2012) Sphingopeptides: dihydrosphingosine-based fusion inhibitors against wild-type and enfuvirtide-resistant HIV-1. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 4628-36 |
| Reuven EM, Dadon Y, Viard M, et al. (2012) HIV-1 gp41 transmembrane domain interacts with the fusion peptide: implication in lipid mixing and inhibition of virus-cell fusion. Biochemistry. 51: 2867-78 |
| Garg H, Viard M, Jacobs A, et al. (2011) Targeting HIV-1 gp41-induced fusion and pathogenesis for anti-viral therapy. Current Topics in Medicinal Chemistry. 11: 2947-58 |
| Ashkenazi A, Viard M, Wexler-Cohen Y, et al. (2011) Viral envelope protein folding and membrane hemifusion are enhanced by the conserved loop region of HIV-1 gp41. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 25: 2156-66 |
| Loomis K, Smith B, Feng Y, et al. (2010) Specific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFv. Experimental and Molecular Pathology. 88: 238-49 |
| Puri A, Kramer-Marek G, Campbell-Massa R, et al. (2008) HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents. Journal of Liposome Research. 18: 293-307 |
| Garg H, Blumenthal R. (2008) Role of HIV Gp41 mediated fusion/hemifusion in bystander apoptosis Cellular and Molecular Life Sciences. 65: 3134-3144 |